ATLAS fair value
ATLAS has no fair value for this stock today.
Caregen Co.Ltd stock price today, ATLAS forecast and fair value
Healthcare · Pharmaceuticals · KOSDAQ · South Korea
Prices as of Oct 27, 2026 · KRW
ATLAS has no fair value for this stock today.
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Caregen Co.Ltd a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩29,094 and ₩37,021; in 9 out of 10, between ₩23,499 and ₩45,836. Estimated annual volatility is 68%.
ATLAS does not publish a fair value for 214370.KQ right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 214370.KQ has traded between ₩33,050 and ₩153,800. Today it is 78.4% below that high and 1% above its low.
Its beta is 0.18: it tends to move less than the market.
Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands.
Want to see everything about Caregen Co.Ltd?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands.
47%: close to a coin flip. In half of the simulated outcomes, 214370.KQ ends the month between ₩29,094 and ₩37,021.
ATLAS estimates annual volatility at 68%. In a typical month, half of the outcomes end between ₩29,094 and ₩37,021.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy